Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | ALPI | P09923 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | XIAP | P98170 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.36 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.36 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1156871 | 0.79 | SLC6A4 (0.41) | CYP3A4CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL1157043 | 0.74 | SLC6A4 (0.60) | CYP1A2CYP2C19SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL1157137 | 0.73 | CYP1A2 (0.47) | CYP3A4CYP1A2CYP2C9CYP2C19SLC6A4 | |
| Hydrochloric Acid SCHEMBL9322405 | 0.73 | SLC6A4 (0.58) | SLC6A4SLC6A2SLC6A3EPHX1CYP2D6 | |
| Hydrochloric Acid SCHEMBL9322527 | 0.73 | SLC6A4 (0.58) | SLC6A4SLC6A2SLC6A3EPHX1CYP2D6 | |
| SCHEMBL6765024 | 0.72 | LMNA (0.40) | CYP3A4CYP1A2SLC6A2ALPIPKM | |
| SCHEMBL9306936 | 0.71 | DPP4 (0.55) | CYP3A4CYP1A2CYP2C9CYP2C19SLC6A4 | |
| SCHEMBL8867023 | 0.71 | SLC6A2 (0.66) | CYP1A2SLC6A4SLC6A2SLC6A3ANPEP | |
| SCHEMBL6890878 | 0.70 | GRIN2D (0.42) | CYP3A4CYP1A2SLC6A4SLC6A2SLC6A3 | |
| SCHEMBL19143563 | 0.70 | CYP3A4 (0.52) | CYP3A4CYP1A2CYP2C9CYP2C19SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140128352-A1 | COMPOUNDS AND METHODS FOR MODULATING MITOCHONDRIAL METABOLISM AND REACTIVE OXYGEN SPECIES PRODUCTION | BUCK INSTITUTE FOR RESEARCH ON AGING (US) | 2014-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140128352-A1 | COMPOUNDS AND METHODS FOR MODULATING MITOCHONDRIAL METABOLISM AND REACTIVE OXYGEN SPECIES PRODUCTION | PC, PCK2, TXNRD2 | CYP3A4 368/4885CYP1A2 480/4885CYP2C9 967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.